Skip to main content

Resources

Explore our growing body of resources and research from across the women’s health innovation ecosystem.

Explore

    2024

    Academic Journal Article
    Autoimmune diseases
    Communicable Diseases
    Global

    DNA-sensing pathways in health, autoinflammatory and autoimmune diseases

    Dong & Fitzgerald

    Summarizes DNA-sensing pathways, their regulation, roles in host defense, and how their dysregulation contributes to autoinflammatory and autoimmune diseases, including therapeutic strategies.

    2024

    Academic Journal Article
    Antimicrobial Resistance (AMR)
    UTIs
    Communicable Diseases
    Asia-Pacific
    Europe
    Global
    North America

    Economic Burden Of Community-Acquired Antibiotic-resistant Urinary Tract Infections: Systematic Review And Meta-analysis

    Zhu et al.

    Synthesizes evidence on the economic, clinical, and health system burden of antibiotic-resistant community-acquired urinary tract infections to inform resource prioritization and intervention evaluation.

    2022

    Academic Journal Article
    Tuberculosis
    Communicable Diseases
    Africa

    Effect of Gender on Clinical Presentation Of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection

    Humayun, M. et al.

    Provides data on gender differences in TB incidence, clinical presentation, and TB-HIV coinfection in Harare, Zimbabwe, to inform targeted interventions.

    2024

    Academic Journal Article
    Pregnancy & Fertility
    Female-Specific Conditions
    Middle East

    Effect of implementation of the WHO intrapartum care model on maternal and neonatal outcomes: a randomized control trial

    Abdolalipour et al.

    Summarizes effects of implementing the WHO intrapartum care model on maternal and neonatal outcomes to improve childbirth experience and care quality.

    2024

    Academic Journal Article
    STIs
    Communicable Diseases
    Asia-Pacific
    Europe
    Global
    North America

    Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis

    Abara et al.

    Summarizes published data on MenB-4C vaccine effectiveness against gonorrhea, including pooled estimates, duration of protection, and implications for vaccine development.

    Effects of Maternal Mortality on Gross Domestic Product (GDP) in the WHO African Region

    2008

    Academic Journal Article
    Abortion
    Postpartum Hemorrhage
    Pre-eclampsia
    Ecosystem Progress
    Africa

    Effects of Maternal Mortality on Gross Domestic Product (GDP) in the WHO African Region

    Kirigia, J. M. et al.

    Estimates and analyzes the negative impact of maternal mortality on GDP in the WHO African Region to inform policy and economic advocacy.

    Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials

    2024

    Academic Journal Article
    Heart Disease
    Non-Communicable and Chronic Conditions
    Asia-Pacific
    Europe
    Latin America & Caribbean
    North America

    Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials

    Verma et al.

    Summarizes recent advances in cardiovascular disease management, providing clinical data and recommendations to guide evidence-based patient care decisions.

    Eliminating HPV-related Cervical Cancer: the Role of Preventive Vaccine R&D

    2025

    Report (Non-Academic)
    Cancer
    Cancer, Cervical
    HPV
    Female-Specific Conditions
    Africa
    Asia-Pacific
    Europe
    Global
    Latin America & Caribbean
    North America

    Eliminating HPV-related Cervical Cancer: the Role of Preventive Vaccine R&D

    Impact Global Health

    Summarizes global HPV vaccine R&D funding, key funders, and progress toward cervical cancer elimination to inform investment and policy decisions.

    Elinzanetant, A New Combined Neurokinin-1/-3 Receptor Antagonist For The Treatment Of Postmenopausal Vasomotor Symptoms

    2024

    Academic Journal Article
    Menopause
    Female-Specific Conditions
    Europe
    North America

    Elinzanetant, A New Combined Neurokinin-1/-3 Receptor Antagonist For The Treatment Of Postmenopausal Vasomotor Symptoms

    Hager et al.

    Summarizes clinical data, safety, and efficacy of Elinzanetant, a neurokinin-1/-3 antagonist, for non-hormonal treatment of postmenopausal vasomotor symptoms and sleep disturbances.

    Emerging Infections and Pregnancy

    2006

    Academic Journal Article
    Pregnancy & Fertility
    Communicable Diseases
    Africa
    Asia-Pacific
    Europe
    Global
    Latin America & Caribbean
    North America

    Emerging Infections and Pregnancy

    Jamieson, D. J. et al.

    Summarizes how pregnancy alters immune response, increasing susceptibility and severity of emerging infectious diseases, to inform clinical and public health planning.

    2006

    Academic Journal Article
    Autoimmune diseases
    Cancer
    Cancer, Cervical
    Cancer, Colon
    Dementia
    Diabetes
    Lupus
    Neurological Disorders
    Tuberculosis
    Communicable Diseases
    Asia-Pacific
    Global
    North America

    Emerging Infectious Determinants of Chronic Diseases

    O’Connor, S. M. et al.

    Summarizes evidence linking infectious agents to chronic diseases, outlines mechanisms involved, and highlights implications for prevention and public health research.

    Endometriosis is Undervalued: A Call To Action

    2022

    Academic Journal Article
    Endometriosis
    Female-Specific Conditions
    Asia-Pacific
    Europe
    Global
    North America

    Endometriosis is Undervalued: A Call To Action

    Ellis, K. et al.

    Summarizes the burden, funding gaps, and current and emerging diagnostic and treatment options for endometriosis to advocate for increased research investment.

Funding Opportunities

Curated global opportunities relevant to women’s health outcomes. 

This list is not meant to be comprehensive — reach out if you are aware of relevant opportunities we should add. Updated every two weeks.

Within 30 days Within 90 days 90+ days away Rolling / periodic
Funder Opportunity Type Focus Deadline
Loading opportunities...
Contact Us
Have a question, partnership idea, or specific request?

We’d love to hear from you.

Contact Us
Name